Inactive Instrument
Argos Therapeutics Inc Stock Nasdaq
Stocks
US0402211033
Pharmaceuticals
OTC Markets Traded| Market Cap | 318K 279K 260K 238K 448K 30.67M 455K 3.08M 1.2M 15.03M 1.19M 1.17M 52.02M | P/E 2016 |
-2.96x | P/E 2017 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 4.58M 4.03M 3.75M 3.44M 6.46M 443M 6.57M 44.53M 17.39M 217M 17.21M 16.84M 751M | EV / Sales 2016 |
200x | EV / Sales 2017 | 9.19x |
| Free-Float |
88.73% | Yield 2016 * |
-
| Yield 2017 | - |
| 1 day | +0.46% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.46% | +1,231.29% | - | - | 567K | |
| +0.63% | -3.06% | +16.18% | -9.78% | 66.74B | |
| +1.23% | +2.80% | +37.51% | +202.14% | 53.32B | |
| +10.08% | +51.80% | +51.80% | +51.80% | 48.12B | |
| -1.32% | -7.38% | -57.63% | -57.10% | 38.25B | |
| +0.78% | -1.84% | +52.49% | -27.01% | 29.85B | |
| +0.84% | +0.36% | +66.93% | +85.42% | 23.51B | |
| -5.17% | -12.54% | +58.98% | -56.04% | 21.45B | |
| -1.21% | +1.12% | +1.98% | +170.93% | 19.97B | |
| -0.22% | -0.95% | +61.97% | +123.78% | 16.38B | |
| Average | +0.61% | -1.00% | +32.25% | +53.79% | 35.29B | |
| Weighted average by Cap. | +1.41% | -0.11% | +27.80% | +49.98% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 945K 832K 773K 710K 1.33M 91.29M 1.35M 9.18M 3.59M 44.75M 3.55M 3.47M 155M | 1.9M 1.67M 1.55M 1.43M 2.68M 183M 2.72M 18.45M 7.2M 89.9M 7.13M 6.98M 311M |
| Net income | -53.03M -46.66M -43.36M -39.81M -74.73M -5.12B -75.98M -515M -201M -2.51B -199M -195M -8.69B | -40.58M -35.7M -33.18M -30.47M -57.18M -3.92B -58.14M -394M -154M -1.92B -152M -149M -6.65B |
| Net Debt | -13.11M -11.53M -10.72M -9.84M -18.47M -1.27B -18.78M -127M -49.71M -620M -49.21M -48.15M -2.15B | 4.27M 3.75M 3.49M 3.2M 6.01M 412M 6.11M 41.44M 16.18M 202M 16.02M 15.67M 699M |
Employees
-
Sector
Pharmaceuticals
